Yes but it is still only Pro-140. Even if the goal is for it to be used for multiple diagnoses, it still has to be approved first. This is why a Buyout is needed. A small company like cydy develops a drug that fits in well with a large pharma that already has a bunch of meds in their arsenal. Makes the most sense.
News 
Market Data 
Discover 
AI
